(Fighting against New Coronary Pneumonia) MGI Made 6 Mobile Nucleic Acid Testing Platforms to Help Guangxi Baise Epidemic Prevention and Control
China News Service, Shenzhen, February 13 (Reporter Zheng Xiaohong) The reporter learned from MGI in Shenzhen on the 12th that according to the current epidemic prevention and control situation in Baise, many hospitals and CDCs in Guangxi quickly mobilized 5 sets of mobile integrated testing cabins , 1 mobile nucleic acid detection vehicle and multiple automated equipment to urgently reinforce Baise.
The six mobile nucleic acid detection platforms deployed this time are independently developed by MGI and provide technical support.
Integrated automated nucleic acid testing laboratory.
Photo courtesy of Huada Manufacturing
Zeng Guangyi, head of MGI's southern area, introduced that MGI's mobile integrated testing cabin has two characteristics of "movable" and "high-throughput" to meet the needs of sudden and flexible epidemic prevention and control.
The 6 sets of mobile nucleic acid detection platforms can realize 24-hour sample collection and detection. If they operate at the same time, the daily detection throughput can reach 50,000 single tubes.
The high-throughput detection capability benefits from the fully automatic MGISTP-7000 sub-cup processing system, the fully automatic MGISTP-3000 sub-cup processing system, and the MGISP-NE384 automatic nucleic acid extraction and purification instrument independently developed by MGI. .
Among them, the MGISP-NE384 automatic nucleic acid extraction and purification instrument adopts the magnetic rod transfer magnetic bead extraction technology, which can efficiently complete the extraction and purification of sample nucleic acid, and plays an important role in many anti-epidemic front lines in the country.
The staff are conducting relevant inspections.
Photo courtesy of Huada Manufacturing
"The automation of these automated systems is very high, which can replace manual labor and can operate 24 hours a day, greatly improving the efficiency of nucleic acid testing, while reducing the risk of errors and infection." The relevant person in charge of MGI said.
(Finish)